Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: A population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix

Cancer

Volumn 92, Issue 9, 2001, Pages 2471-2483

  Ceciliealfsen, G ^a   Kristensen, Gunnar B ^a   Skovlund, Eva ^a   Pettersen, Erik O ^b   Abeler, Vera M ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Adenocarcinoma; Cervical carcinoma; Prognosis; Prognostic factors; Small cell carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NORWAY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL; TREATMENT PLANNING; UTERUS CARCINOMA;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; CARCINOMA, SMALL CELL; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0035498662     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011101)92:9<2471::AID-CNCR1597>3.0.CO;2-K     Document Type: Article

References (46)

1. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: A population-based epidemiologic study
2. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups. A population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990
3. Incidence, survival and mortality in cervical cancer in Norway, 1956-1990
4. Recent trends in cervix uteri cancer
5. Cancer of the uterine cervix in Norway by histologic type, 1970-84
6. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County
7. The changing pattern of cervical cancer in Northern Ireland 1965-1989
8. Increased incidence of adenocarcinoma of the cervix in young women in the United States
9. Prognostic factors of primary adenocarcinoma of the uterine cervix
10. Adenocarcinoma as an independent risk factor for disease recurrence in patients with Stage IB cervical carcinoma
11. Gland cell carcinoma (adenocarcinoma) of the cervix
12. Tumors of the cervix, vagina, and vulva
13. Microinvasive carcinoma in gynaecological pathology
14. Method for analysis of cellular DNA content of paraffinembedded pathological material using flow cytometry
15. Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary
16. Classification and staging of malignant tumours in the female pelvis
17. TNM classification of malignant tumors, fifth edition (1997)
18. Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival
19. Prognostic factors of adenocarcinoma of the uterine cervix
20. Adenocarcinoma of the uterine cervix metastatic to lymph nodes
21. Cervical carcinoma with glandular differentiation: Histological evaluation predicts disease recurrence in clinical Stage I or II patients
22. Adenocarcinoma of the uterine cervix: Prognostic factors and patterns of recurrence
23. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix
24. Adenocarcinoma of the cervix: Histopathologic and clinical features
25. Analysis of prognostic features in adenocarcinoma of the cervix
26. Prognosis of the adenocarcinoma of the cervix uteri: A comparative study
27. Adenocarcinoma of the uterine cervix. Prognosis and prognostic significance of histology
28. An analysis of cell type in patients with surgically staged Stage IB carcinoma of the cervix: A Gynecologic Oncology Group study
29. Stage I cervical adenocarcinoma: Prognostic evaluation of surgically treated patients
30. Prognostic factors in adenocarcinoma of the uterine cervix
31. Adenocarcinoma of the cervix I. Clinical evaluation and pathologic features
32. Adenocarcinoma of the uterine cervix
33. Prognosis and prognostic factors in node-negative cervix cancer
34. Prognostic factors in uterine cervical carcinom: A clinicopathological analysis
35. Prognostic factors in the treatment of Stage IB adenocarcinoma of the cervix
36. Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in Stage IB and II cervical cancer patients undergoing primary radical surgery?
37. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
38. Clear cell adenocarcinoma of the cervix uteri and vagina in young women in Norway
39. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan
40. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy
41. Thickness of uninvolved fibromuscular stroma and extrauterine spread of carcinoma of the uterine cervix
42. Influence of HSP27 and steroid receptor status on provera sensitivity, DNA-ploidy and survival of females with endometrial cancer
43. Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse
44. Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: Prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction
45. Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture
46. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: A prospective study of 465 patients